A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Homozygous familial hypercholesterolemia (HoFH) is a genetic condition characterized by lethally high levels of low-density lipoprotein cholesterol (LDL-C) from birth, and requires rapid and aggressive intervention to prevent death due to coronary heart disease and/or atherosclerosis. Where available, lipoprotein apheresis (LA) is the mainstay of treatment to promote survival.

Source: Atherosclerosis - January 21, 2018 Category: Cardiology Authors: Meral Kayikcioglu, Lale Tokgozoglu, Mehmet Yilmaz, Leylagul Kaynar, Melih Aktan, Rana Berru Durmu ş, Cumali Gokce, Ahmet Temizhan, Osman Ilhami Ozcebe, Tulay Karaagac Akyol, Harika Okutan, Saim Sag, Ozen Oz Gul, Zafer Salcioglu, Mustafa Yenercag, Bulent Source Type: research